Back
Armata Pharmaceuticals Stock Price Chart
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Buy
86
ARMP
Armata Pharmaceuticals
Last Price:
2.69
Seasonality Move:
12.82%
7 Day Trial
ALL ACCESS PASS
$
7
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More Here- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARMP is experiencing selling pressure, which indicates risk of future bearish movement.
Armata Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.43 | Buy |
| 20-day SMA: | 2.38 | Buy |
| 50-day SMA: | 2.34 | Buy |
| 200-day SMA: | 2.84 | Sell |
| 8-day EMA: | 2.51 | Buy |
| 20-day EMA: | 2.42 | Buy |
| 50-day EMA: | 2.4 | Buy |
| 200-day EMA: | 2.63 | Buy |
Armata Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.06 | Buy |
| Relative Strength Index (14 RSI): | 64.56 | Buy |
| Chaikin Money Flow: | -1753 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.25 - 2.51) | Buy |
| Bollinger Bands (100): | (2.24 - 2.76) | Buy |
Armata Pharmaceuticals Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Armata Pharmaceuticals Stock
Is Armata Pharmaceuticals Stock a Buy?
- Armata Pharmaceuticals share price is 2.68 while ARMP 8-day simple moving average is 2.43, which is a Buy signal.
- The stock price of ARMP is 2.68 while Armata Pharmaceuticals 20-day SMA is 2.38, which makes it a Buy.
- Armata Pharmaceuticals 50-day simple moving average is 2.34 while ARMP share price is 2.68, making it a Buy technically.
- ARMP stock price is 2.68 and Armata Pharmaceuticals 200-day simple moving average is 2.84, creating a Sell signal.
ARMP Technical Analysis vs Fundamental Analysis
Buy
86
Armata Pharmaceuticals (ARMP)
is a Buy
Is Armata Pharmaceuticals a Buy or a Sell?
-
Armata Pharmaceuticals stock is rated a Buy
The current Armata Pharmaceuticals [ARMP] share price is $2.68. The Score for ARMP is 86, which is 72% above its historic median score of 50, and infers lower risk than normal.
Armata Pharmaceuticals Stock Info
Market Cap:
96.97M
Price in USD:
2.68
Share Volume:
1.75K
Armata Pharmaceuticals 52-Week Range
52-Week High:
4.48
52-Week Low:
1.93
Buy
86
Armata Pharmaceuticals (ARMP)
is a Buy
Armata Pharmaceuticals Share Price Forecast
-
What is the Armata Pharmaceuticals stock price today?
The Armata Pharmaceuticals stock price is 2.68 USD today. -
Will ARMP stock go up or go down?
Armata Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Armata Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Armata Pharmaceuticals is not overvalued.
Is Armata Pharmaceuticals Stock a Buy?
- Armata Pharmaceuticals share price is 2.68 while ARMP 8-day exponential moving average is 2.51, which is a Buy signal.
- The stock price of ARMP is 2.68 while Armata Pharmaceuticals 20-day EMA is 2.42, which makes it a Buy.
- Armata Pharmaceuticals 50-day exponential moving average is 2.40 while ARMP share price is 2.68, making it a Buy technically.
- ARMP stock price is 2.68 and Armata Pharmaceuticals 200-day simple moving average is 2.63, creating a Buy signal.
Fundamental Analysis of Armata Pharmaceuticals
Is Armata Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and an increase next year of $0.52 per share.
Technical Analysis of Armata Pharmaceuticals
Should I short Armata Pharmaceuticals stock?
- ARMP Moving Average Covergence Divergence (MACD) indicator is 0.06, suggesting Armata Pharmaceuticals is a Buy
- Armata Pharmaceuticals Relative Strength Index (RSI) is 64.56, which suggest Armata Pharmaceuticals is overbought
- The Bollinger Bands (25) for Armata Pharmaceuticals is (2.25 - 2.51), which suggest Armata Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Armata Pharmaceuticals is (2.24 - 2.76), which suggest Armata Pharmaceuticals is a Buy
* Armata Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.